# Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance

> **NCT01079884** · NA · COMPLETED · sponsor: **David A. Johnson, MD** · enrollment: 18 (actual)

## Conditions studied

- GERD

## Interventions

- **DRUG:** esomeprazole 40 mg

## Key facts

- **NCT ID:** NCT01079884
- **Lead sponsor:** David A. Johnson, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01079884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01079884, "Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01079884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*